A
Andreas Barratt-Due
Researcher at Oslo University Hospital
Publications - 80
Citations - 4155
Andreas Barratt-Due is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 20, co-authored 61 publications receiving 2353 citations. Previous affiliations of Andreas Barratt-Due include University of Oslo.
Papers
More filters
Journal ArticleDOI
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Hongchao Pan,Richard Peto,Ana-Maria Henao-Restrepo,Marie-Pierre Preziosi,Vasee Sathiyamoorthy,Quarraisha Abdool Karim,Marissa M. Alejandria,César Hernández García,Marie-Paule Kieny,Reza Malekzadeh,Srinivas Murthy,K. Srinath Reddy,Mirta Roses Periago,Pierre Abi Hanna,Florence Ader,Abdullah M. Al-Bader,Almonther Alhasawi,Emma Allum,Athari Alotaibi,Carlos A Alvarez-Moreno,Sheila Appadoo,Abdullah Asiri,Pål Aukrust,Andreas Barratt-Due,Samir Bellani,Mattia Branca,Heike B. C. Cappel-Porter,Nery Cerrato,Ting S. Chow,Najada Como,Joseph A. Eustace,Patricia J. Garcia,Sheela Godbole,Eduardo Gotuzzo,Laimonas Griskevicius,Rasha Hamra,Mariam Hassan,Mohamed Hassany,David Hutton,Irmansyah Irmansyah,Ligita Jancoriene,Jana Kirwan,Suresh Kumar,Peter Lennon,Gustavo Lopardo,Patrick Lydon,Nicola Magrini,Teresa Maguire,Suzana Manevska,Oriol Manuel,Sibylle McGinty,Marco T. Medina,María L. Mesa Rubio,Maria C. Miranda-Montoya,Jeremy Nel,Estevão Portela Nunes,Markus Perola,Antonio Portolés,Menaldi R. Rasmin,Aun Raza,Helen Rees,Paula P. S. Reges,Chris A Rogers,Kolawole Salami,Marina I. Salvadori,Narvina Sinani,Jonathan A C Sterne,Milena Stevanovikj,Evelina Tacconelli,Kari A.O. Tikkinen,Sven Trelle,Hala Zaid,John-Arne Røttingen,Soumya Swaminathan +73 more
TL;DR: These remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay.
Posted ContentDOI
Repurposed antiviral drugs for COVID-19: interim WHO solidarity trial results (Preprint)
Pan Hongchao,Richard Peto,Ana-Maria Henao-Restrepo,Marie-Pierre Preziosi,Vasee Sathiyamoorthy,Quarraisha Abdool Karim,Marissa M. Alejandria,César Hernández García,Marie-Paule Kieny,Reza Malekzadeh,Srinivas Murthy,K. Srinath Reddy,Mirta Roses Periago,Pierre Abi Hanna,Florence Ader,Abdullah M. Al-Bader,Almonther Alhasawi,Emma Allum,Athari Alotaibi,Carlos Alvarez-Moreno,Sheila Appadoo,Abdullah Asiri,Pål Aukrust,Andreas Barratt-Due,Samir Bellani,Mattia Branca,Heike B. C. Cappel-Porter,Nery Cerrato,Ting S. Chow,Najada Como,Joseph A. Eustace,Patricia J. Garcia,Sheela Godbole,Eduardo Gotuzzo,Laimonas Griskevicius,Rasha Hamra,Mariam Hassan,Mohamed Hassany,David W. Hutton,Irmansyah Irmansyah,Ligita Jancoriene,Jana Kirwan,Suresh Kumar,Peter Lennon,Gustavo Lopardo,Patrick Lydon,Nicola Magrini,Teresa Maguire,Suzana Manevska,Oriol Manuel,Sibylle McGinty,Marco T. Medina,María L. Mesa Rubio,Maria C. Miranda-Montoya,Jeremy Nel,Estevão Portela Nunes,Markus Perola,Antonio Portolés,Menaldi R. Rasmin,Aun Raza,Helen Rees,Paula P. S. Reges,Chris A Rogers,Kolawole Salami,Marina I. Salvadori,Narvina Sinani,Jonathan A C Sterne,Milena Stevanovikj,Evelina Tacconelli,Kari A.O. Tikkinen,Sven Trelle,Hala Zaid,John-Arne Røttingen,Soumya Swaminathan,Múltipla ver em Notas +74 more
TL;DR: These Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens appeared to have little or no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation and duration of hospital stay.
Journal ArticleDOI
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
Jan Cato Holter,Jan Cato Holter,Soeren Erik Pischke,Soeren Erik Pischke,Eline de Boer,Eline de Boer,Andreas Lind,Synne Jenum,Aleksander Rygh Holten,Aleksander Rygh Holten,Kristian Tonby,Kristian Tonby,Andreas Barratt-Due,Andreas Barratt-Due,Marina Sokolova,Marina Sokolova,Camilla Schjalm,Camilla Schjalm,Viktoriia Chaban,Viktoriia Chaban,Anette Kolderup,Trung Tran,Torleif Tollefsrud Gjølberg,Torleif Tollefsrud Gjølberg,Linda Gail Skeie,Liv Hesstvedt,Vidar Ormåsen,Vidar Ormåsen,Børre Fevang,Cathrine Austad,Karl Erik Müller,Karl Erik Müller,Cathrine Fladeby,Mona Holberg-Petersen,Bente Halvorsen,Bente Halvorsen,Fredrik Müller,Fredrik Müller,Pål Aukrust,Pål Aukrust,Pål Aukrust,Susanne Gjeruldsen Dudman,Susanne Gjeruldsen Dudman,Thor Ueland,Thor Ueland,Thor Ueland,Jan Terje Andersen,Jan Terje Andersen,Fridtjof Lund-Johansen,Fridtjof Lund-Johansen,Lars Heggelund,Lars Heggelund,Anne Ma Dyrhol-Riise,Anne Ma Dyrhol-Riise,Tom Eirik Mollnes +54 more
TL;DR: In this paper, a prospective cohort study of 39 hospitalized coronavirus disease COVID-19 patients, the authors describe systemic complement activation and its association with development of respiratory failure.
Journal ArticleDOI
Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study
Elie Azoulay,Peter Pickkers,Marcio Soares,Anders Perner,Jordi Rello,Philippe R. Bauer,Andry Van de Louw,Pleun Hemelaar,Virginie Lemiale,Fabio Silvio Taccone,Ignacio Martin Loeches,Tine Sylvest Meyhoff,Jorge I. F. Salluh,Peter Schellongowski,Katerina Rusinova,Nicolas Terzi,Sangeeta Mehta,Massimo Antonelli,Achille Kouatchet,Andreas Barratt-Due,Miia Valkonen,Precious Pearl Landburg,Fabrice Bruneel,Ramin Brandt Bukan,Frédéric Pène,Victoria Metaxa,Anne Sophie Moreau,Virginie Souppart,Gastón Burghi,Christophe Girault,Ulysses V. A. Silva,Luca Montini,François Barbier,Lene B. Nielsen,Benjamin Gaborit,Djamel Mokart,Sylvie Chevret,Efraim investigators +37 more
TL;DR: HFNC has an effect on intubation but not on mortality rates; however, IMV was associated with mortality, the odds ratio depending on IMV conditions: NIV + HFNC failure (2.31, 1.09–4.91), first-line IMV (1.94–3.29), NIV failure (3.05–6.53), standard oxygen failure (4.27–9.38).
Journal ArticleDOI
The role of complement in liver injury, regeneration and transplantation
Ebbe Billmann Thorgersen,Andreas Barratt-Due,Håkon Haugaa,Morten Harboe,Søren Erik Pischke,Per H. Nilsson,Per H. Nilsson,Tom Eirik Mollnes,Tom Eirik Mollnes,Tom Eirik Mollnes +9 more
TL;DR: It is argued that complement is a key system to manipulate in the liver in several clinical settings, including liver injury and regeneration after major surgery and preservation of the organ during transplantation.